PTEN and neoplasm: The PI3K/mTOR pathway was again implicated when analysing the expression profiles of PanNETs, with a particularly evident association between low PTEN and TSC2 expression levels and development of metastasis, tumour progression and poor overall survival (Missiaglia et al. 2010).